524280 logo

Kopran Stock Price

Symbol: BSE:524280Market Cap: ₹7.8bCategory: Pharmaceuticals & Biotech

524280 Share Price Performance

₹158.40
-82.95 (-34.37%)
₹158.40
-82.95 (-34.37%)
Price ₹158.40

524280 Community Narratives

There are no narratives available yet.

Community Fair Values

    Recent 524280 News & Updates

    No updates

    Kopran Limited Key Details

    ₹6.3b

    Revenue

    ₹4.0b

    Cost of Revenue

    ₹2.2b

    Gross Profit

    ₹1.9b

    Other Expenses

    ₹349.1m

    Earnings

    Last Reported Earnings
    Jun 30, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    7.23
    Gross Margin
    35.38%
    Net Profit Margin
    5.58%
    Debt/Equity Ratio
    28.5%

    Kopran Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 524280

    Founded
    1958
    Employees
    842
    CEO
    Surendra Somani
    WebsiteView website
    www.kopran.com

    Kopran Limited, an integrated pharmaceutical company, engages in the manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-acne, anti-infective, anti-thrombotic, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.

    Indian Market Performance

    • 7 Days: -0.8%
    • 3 Months: 4.5%
    • 1 Year: -2.1%
    • Year to Date: -1.3%
    In the last week, the market has been flat, with a notable exception in the Healthcare sector dropping 3.5%. In line with that, the market has also been flat over the past year. Earnings are forecast to grow by 15% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading